𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

✍ Scribed by Morice, M.-C.; Serruys, P. W.; Kappetein, A. P.; Feldman, T. E.; Stahle, E.; Colombo, A.; Mack, M. J.; Holmes, D. R.; Torracca, L.; van Es, G.-A.; Leadley, K.; Dawkins, K. D.; Mohr, F.

Book ID
118063561
Publisher
Lippincott Williams and Wilkins
Year
2010
Tongue
English
Weight
583 KB
Volume
121
Category
Article
ISSN
0009-7322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic outcomes of percutaneous corona
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial
✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery